Northern Trust’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Sell |
|
|||||
|
2025
Q1 | $2.56M | Sell |
|
|||||
|
2024
Q4 | $2.45M | Buy |
|
|||||
|
2024
Q3 | $2.33M | Buy |
|
|||||
|
2024
Q2 | $1.15M | Sell |
|
|||||
|
2024
Q1 | $2.14M | Sell |
|
|||||
|
2023
Q4 | $2.24M | Buy |
|
|||||
|
2023
Q3 | $1.64M | Buy |
|
|||||
|
2023
Q2 | $1.95M | Sell |
|
|||||
|
2023
Q1 | $2.01M | Buy |
|
|||||
|
2022
Q4 | $2.26M | Sell |
|
|||||
|
2022
Q3 | $1.91M | Sell |
|
|||||
|
2022
Q2 | $1.86M | Sell |
|
|||||
|
2022
Q1 | $5.08M | Sell |
|
|||||
|
2021
Q4 | $4.72M | Buy |
|
|||||
|
2021
Q3 | $6.38M | Sell |
|
|||||
|
2021
Q2 | $7.81M | Sell |
|
|||||
|
2021
Q1 | $6.4M | Sell |
|
|||||
|
2020
Q4 | $6.89M | Sell |
|
|||||
|
2020
Q3 | $4.78M | Sell |
|
|||||
|
2020
Q2 | $3.87M | Sell |
|
|||||
|
2020
Q1 | $3.31M | Sell |
|
|||||
|
2019
Q4 | $4.58M | Buy |
|
|||||
|
2019
Q3 | $3.9M | Buy |
|
|||||
|
2019
Q2 | $5.3M | Buy |
|
|||||
|
2019
Q1 | $5.16M | Sell |
|
|||||
|
2018
Q4 | $4.63M | Sell |
|
|||||
|
2018
Q3 | $6.59M | Buy |
|
|||||
|
2018
Q2 | $5.65M | Buy |
|
|||||
|
2018
Q1 | $6.29M | Buy |
|
|||||
|
2017
Q4 | $6.75M | Buy |
|
|||||
|
2017
Q3 | $3.78M | Buy |
|
|||||
|
2017
Q2 | $4.01M | Buy |
|
|||||
|
2017
Q1 | $4.51M | Buy |
|
|||||
|
2016
Q4 | $2.63M | Buy |
|
|||||
|
2016
Q3 | $3.79M | Buy |
|
|||||
|
2016
Q2 | $2.28M | Buy |
|
|||||
|
2016
Q1 | $1.98M | Buy |
|
|||||
|
2015
Q4 | $2.86M | Buy |
|
|||||
|
2015
Q3 | $2.25M | Buy |
|
|||||
|
2015
Q2 | $2.72M | Sell |
|
|||||
|
2015
Q1 | $3.15M | Sell |
|
|||||
|
2014
Q4 | $2.04M | Sell |
|
|||||
|
2014
Q3 | $1.87M | Sell |
|
|||||
|
2014
Q2 | $3.79M | Sell |
|
|||||
|
2014
Q1 | $4.35M | Sell |
|
|||||
|
2013
Q4 | $3.48M | Buy |
|
|||||
|
2013
Q3 | $4.26M | Sell |
|
|||||
|
2013
Q2 | $4.07M | Buy |
|